Shorter course of ADT for high-risk prostate cancer patients yields improved quality of life

(American Society for Radiation Oncology) High-risk prostate cancer patients who receive radiation therapy and an 18-month course of androgen deprivation therapy recover a normal testosterone level in a shorter amount of time compared to those who receive a 36-month course of ADT, thus resulting in a better quality of life and without detriment to long-term outcomes, according to research presented today at the American Society for Radiation Oncology's 56th Annual Meeting.